Explore FHI 360

News

FHI 360 and partners to lead USAID expansion of HIV prevention for women

FHI 360 will lead the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) project to help women in multiple countries in sub-Saharan Africa protect themselves from HIV.

Published research

Brief report: Herpes simplex virus type-2 shedding and genital ulcers during early HIV in Zimbabwean women

Published research

Risk factors for TB/HIV coinfection and consequences for patient outcomes: Evidence from 241 clinics in the Democratic Republic of Congo

Published research

Disparities in HIV clinical stages progression of patients at outpatient clinics in Democratic Republic of Congo

Project

National Aligned HIV/AIDS Initiative (NAHI)

The NAHI project works to reduce the incidence of new HIV infections, mortality and morbidity in Nigeria, particularly for key and vulnerable populations.

Project

Technical Assistance to the Eastern Province Health Office (EPHO) in Zambia to Support Optimized HIV Case Finding, Treatment, Viral Suppression, Retention and HIV Epidemic Control under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)

The EPHO project provides technical assistance to the Eastern Provincial Health Office (EPHO) of Zambia to provide scaled, comprehensive and sustainable HIV prevention, care, treatment and support.

Publication

Enhanced Peer Outreach Approach and Social Networking Strategy (EPOA/SNS): Orientation Curriculum for Peer Leaders: Facilitator Guide

This curriculum and facilitator guide provides an orientation for prospective volunteer peer leaders in effective social network-based outreach approaches and Open Door project expectations.

Published research

Breakthrough tuberculosis disease among people with HIV - should we be worried? A retrospective longitudinal study

This paper measured the level of breakthrough tuberculosis (TB) among people with HIV who were taking a standard of care treatment, isoniazid preventive therapy. The authors found that breakthrough TB was uncommon in this group and recommend starting preventive TB treatment while HIV patients are at higher CD4 counts.

Publication

Trainer's Guide: Group Savings and Loan Associations

This guide will assist trainers to provide a step-by-step approach to self-help groups learning to manage the savings and loan process.

Published research

High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: Results from a nationwide surveillance in Nigeria

The study found a high prevalence of pretreatment HIV drug resistance, predominantly nonnucleoside reverse transcriptase inhibitor-based regimen (NNRTI) associated, among HIV-infected children (less than 18 months) in Nigeria. The findings support using a non-NNRTI regimen in children less than 3 years of age as a preferred first-line antiretroviral treatment regimen, as recommended by the World Health Organization. Child-friendly, fixed-dose, combination co-formulated drugs need to be widely available in the country.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

FHI 360 and partners to lead USAID expansion of HIV prevention for women

Brief report: Herpes simplex virus type-2 shedding and genital ulcers during early HIV in Zimbabwean women

Risk factors for TB/HIV coinfection and consequences for patient outcomes: Evidence from 241 clinics in the Democratic Republic of Congo

Disparities in HIV clinical stages progression of patients at outpatient clinics in Democratic Republic of Congo

National Aligned HIV/AIDS Initiative (NAHI)

Technical Assistance to the Eastern Province Health Office (EPHO) in Zambia to Support Optimized HIV Case Finding, Treatment, Viral Suppression, Retention and HIV Epidemic Control under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)

Enhanced Peer Outreach Approach and Social Networking Strategy (EPOA/SNS): Orientation Curriculum for Peer Leaders: Facilitator Guide

Breakthrough tuberculosis disease among people with HIV - should we be worried? A retrospective longitudinal study

Trainer's Guide: Group Savings and Loan Associations

High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: Results from a nationwide surveillance in Nigeria

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

33 Results Found

Breakthrough tuberculosis disease among people with HIV - should we be worried? A retrospective longitudinal study

High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: Results from a nationwide surveillance in Nigeria